Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$6.19M Buy
79,543
+2,432
+3% +$174K 0.17% 136
2017
Q1
$5.55M Sell
77,111
-2,447
-3% -$169K 0.17% 140
2016
Q4
$4.94M Buy
79,558
+2,682
+3% +$164K 0.16% 147
2016
Q3
$4.98M Buy
76,876
+3,857
+5% +$257K 0.15% 120
2016
Q2
$4.62M Hold
73,019
0.16% 119
2016
Q1
$4.22M Buy
73,019
+54,760
+300% +$3.1M 0.14% 128
2015
Q4
$980K Sell
18,259
-44,150
-71% -$2.49M 0.03% 362
2015
Q3
$3.18M Buy
62,409
+4,968
+9% +$267K 0.1% 170
2015
Q2
$3.24M Buy
57,441
+20,000
+53% +$1.26M 0.1% 168
2015
Q1
$2.69M Buy
37,441
+32,744
+697% +$2.13M 0.08% 147
2014
Q4
$263K Hold
4,697
0.01% 623
2014
Q3
$231K Hold
4,697
﹤0.01% 613
2014
Q2
$238K Hold
4,697
0.01% 599
2014
Q1
$210K Hold
4,697
0.01% 585
2013
Q4
$221K Hold
4,697
0.01% 563
2013
Q3
$248K Buy
+4,697
New +$228K 0.01% 500

Other funds holding RMD

Delta Lloyd's RMD Position: Q2 2017 in Review

Delta Lloyd increased its ResMed (RMD) stake by 3.2% in Q2 2017, buying an estimated $174K and bringing the position to 79,543 shares worth $6.19M. The position accounts for 0.17% of the portfolio, ranked #136.

Delta Lloyd first reported a position in RMD in Q3 2013 and has held it in 16 quarters since. 339 funds tracked by Wall St. Rank hold RMD as of Q2 2017.

  • Delta Lloyd held 79,543 shares of ResMed worth $6.19M as of Q2 2017.
  • Delta Lloyd bought 2,432 ResMed shares in Q2 2017, an estimated $174K.
  • ResMed made up 0.17% of Delta Lloyd's portfolio in Q2 2017, its #136 holding.
  • Delta Lloyd first reported a position in ResMed in Q3 2013 and has held it in 16 quarters since.
  • 339 funds tracked by Wall St. Rank held ResMed as of Q2 2017.

Based on Delta Lloyd's 13F filing for Q2 2017, filed 9 Aug 2017.